News & Events

News & Events

News

November 11, 2024

ARTHEx Biotech Announces Oral Presentation on ATX-01 at TIDES Europe Annual Meeting 2024

November 7, 2024

ARTHEx Biotech Announces FDA Rare Pediatric Designation (RPD) of ATX-01 for the Treatment of Myotonic Dystrophy Type 1 (DM1)

October 18, 2024

ARTHEx Biotech Announces First Patient Dosed in Phase I-IIa ArthemiR™ Trial for Myotonic Dystrophy Type 1 (DM1)

October 15, 2024

ARTHEx Biotech Announces Publication of Promising Preclinical Research for Myotonic Dystrophy Type 1 (DM1)

September 25, 2024

ARTHEx Biotech Announces Participation in 8th Annual Chardan Genetic Medicines Conference

ARTHEx Biotech Announces Participation in Barclays Biotech: 1x1 Private Company Symposium

ARTHEx Biotech Announces Oral Presentation on ATX-01 at the Oligonucleotide & Peptide Therapeutics (TIDES) Conference 2024

ARTHEx Biotech Announces Participation at the 23rd Annual Needham Virtual Healthcare Conference

February 28, 2024

ARTHEx Biotech Receives IND Clearance from FDA to Initiate the Phase I-IIa ArthemiR™ Trial of ATX-01 for Myotonic Dystrophy Type 1 (DM1)

Events

September 30 - October 1, 2024

8th Annual Chardan Genetic Medicines Conference

Barclays Biotech: 1x1 Private Company Symposium

May 14 - 17, 2024

Oligonucleotide & Peptide Therapeutics(TIDES) Conference 2024

April 8-11, 2024

23rd Annual Needham Virtual Healthcare Conference

October 30 - November 1, 2023

Tides Europe 2023

October 26 - 27, 2023

Spanish Meeting on Oligonucleotide Therapeutics (SMOT III)

October 22-25, 2023

19th Annual Meeting of the Oligonucleotide Therapeutics Society (OTS)

September 6–7, 2023

RNA Leaders USA Congress

May 7 – 10, 2023 | San Diego, CA USA

TIDES USA - Oligonucleotide & Peptide Therapeutics

November 16-18, 2022, Vienna

October 2-5,2022, Phoenix

18th Annual Meeting of the Oligonucleotide Therapeutics Society

September 9-10, 2022; San Diego

2022 MDF Annual Conference

Bassel. September 21-22, 2022

22ND ANNUAL BIOTECH IN EUROPE FORUM

October 17-18, 2023

3rd Annual Needham Private Biotech Company Virtual 1x1 Forum